Build for the future now with Mammoth Biosciences and Mayfield

2017-08-24_00h03_35 IT総合






Trevor Martin’s Mammoth Biosciences aims to use CRISPR technology to democratize disease detection. Join this TechCrunch Live event to hear from Trevor Martin and Mayfield investor Ursheet Parikh on how Mammoth Biosciences positioned itself to achieve the lofty goal. Spoiler: Trevor Martin spent time putting the basics in place to ensure future success.





This TechCrunch Live event opens on October 5 at 11:30 a.m. PDT/2:30 p.m. EDT with networking. The interview begins at 12:00 p.m. PDT followed by the TCL Pitch Practice at 12:30 p.m. PDT.
Apply for TCL Pitch Practice by co

リンク元

コメント

タイトルとURLをコピーしました